GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,562.60p
   
  • Change Today:
      11.00p
  • 52 Week High: 1,619.40
  • 52 Week Low: 1,242.80
  • Currency: UK Pounds
  • Shares Issued: 4,960.56m
  • Volume: 9,038,741
  • Market Cap: 77,514m
  • RiskGrade: 101
  • Beta: 1.02

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (15-11-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.1% 5.1%
Div Cover 1.4 1.4
Op Mrgn 13.5% 25.6%
ROCE n/a  
Latest F'cast
P/E 14.0 13.7
PEG 1.5 6.6
Pr/Revenue 2.6 2.5
Pr/Book 22.2  
Latest F'cast
Revenue 8.2% 1.0%
PBT 81.8% 121.6%
EPS 9.2% 2.1%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 30,492.59 7,810.79 114.13p 13.7 6.6 +2% 80.00p 5.1%
31-Dec-19 31,263.86 7,843.32 117.31p 13.3 4.8 +3% 80.24p 5.1%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 12-Nov-2018 14:45 RNS
Blocklisting Application 12-Nov-2018 09:00 RNS
Director Declaration 08-Nov-2018 12:43 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
09-Nov-18 Transfer From Victoria Whyte 0.000p 8 0.00
09-Nov-18 Buy Victoria Whyte 1,561.10p 8 124.89
09-Nov-18 Buy Emma Walmsley 1,561.10p 8 124.89

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,562.60p
Change Today 11.00p
% Change 0.71 %
52 Week High 1,619.40
52 Week Low 1,242.80
Volume 9,038,741
Shares Issued 4,960.56m
Market Cap 77,514m
Beta 1.02
RiskGrade 101

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
79.31% below the market average79.31% below the market average79.31% below the market average79.31% below the market average79.31% below the market average
51.72% below the sector average51.72% below the sector average51.72% below the sector average51.72% below the sector average51.72% below the sector average
Price Trend
73.39% above the market average73.39% above the market average73.39% above the market average73.39% above the market average73.39% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income
62.52% above the market average62.52% above the market average62.52% above the market average62.52% above the market average62.52% above the market average
84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average
Growth
32.81% above the market average32.81% above the market average32.81% above the market average32.81% above the market average32.81% above the market average
5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average

What The Brokers Say

Strong Buy 9
Buy 1
Neutral 14
Sell 0
Strong Sell 1
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q3 Q2
Ex-Div 15-Nov-18 09-Aug-18
Paid 10-Jan-19 11-Oct-18
Amount 19.00p 19.00p

Trades for 15-Nov-2018

Time Volume / Share Price
17:06 59 @ 1,557.33p
16:57 9,304 @ 1,559.80p
16:57 9,010 @ 1,572.04p
16:57 13,940 @ 1,570.28p
16:57 11,161 @ 1,554.78p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page